PTC299

· PTC Therapeutics

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PTC299, covering 2012-03-05 to 2015-05-04. Get the full timeline:

Most recent: Clinical Trial Update: PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors [Phase 1]